Skip to main content
Top
Published in: Skeletal Radiology 4/2023

03-11-2022 | osteosarcoma | Review Article

Update of pediatric bone tumors: osteogenic tumors and osteoclastic giant cell-rich tumors

Authors: Khalid Al-Dasuqi, Ryan Cheng, Jay Moran, Lina Irshaid, Ezekiel Maloney, Jack Porrino

Published in: Skeletal Radiology | Issue 4/2023

Login to get access

Abstract

There are numerous bone tumors in the pediatric population, with imaging playing an essential role in diagnosis and management. Our understanding of certain bone tumors has rapidly evolved over the past decade with advancements in next-generation genetic sequencing techniques. This increased level of understanding has altered the nomenclature, management approach, and prognosis of certain lesions. We provide a detailed update of bone tumors that occur in the pediatric population with emphasis on the recently released nomenclature provided in the 5th edition of the World Health Organization Classification of Soft Tissue and Bone Tumours.
Literature
1.
go back to reference WHO classification of soft tissue and bone tumours. Fifth Edition. WHO IARC WHO Classification of Tumours 2020;3. WHO classification of soft tissue and bone tumours. Fifth Edition. WHO IARC WHO Classification of Tumours 2020;3.
2.
go back to reference Choi JH, Ro JY. The 2020 WHO classification of tumors of bone: an updated review. Adv Anat Pathol. 2021;28:119–38.CrossRefPubMed Choi JH, Ro JY. The 2020 WHO classification of tumors of bone: an updated review. Adv Anat Pathol. 2021;28:119–38.CrossRefPubMed
3.
go back to reference Anderson WJ, Doyle LA. Updates from the 2020 World Health Organization classification of soft tissue and bone tumours. Histopathology. 2021;78:644–57.CrossRefPubMed Anderson WJ, Doyle LA. Updates from the 2020 World Health Organization classification of soft tissue and bone tumours. Histopathology. 2021;78:644–57.CrossRefPubMed
4.
go back to reference Lam SW, Cleven AHG, Kroon HM, Briaire-de Bruijn IH, Szuhai K, Bovée JVMG. Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma. Virchows Arch. 2020;476:455–63.CrossRefPubMed Lam SW, Cleven AHG, Kroon HM, Briaire-de Bruijn IH, Szuhai K, Bovée JVMG. Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma. Virchows Arch. 2020;476:455–63.CrossRefPubMed
5.
go back to reference Bhusnurmath S, Hoch B. Benign bone-forming tumors: approach to diagnosis and current understanding of pathogenesis. Surg Pathol Clin. 2012;5:101–16.CrossRefPubMed Bhusnurmath S, Hoch B. Benign bone-forming tumors: approach to diagnosis and current understanding of pathogenesis. Surg Pathol Clin. 2012;5:101–16.CrossRefPubMed
6.
go back to reference Chai JW, Hong SH, Choi J-Y, Koh YH, Lee JW, Choi J-A, et al. Radiologic diagnosis of osteoid osteoma: from simple to challenging findings. Radiographics. 2010;30:737–49.CrossRefPubMed Chai JW, Hong SH, Choi J-Y, Koh YH, Lee JW, Choi J-A, et al. Radiologic diagnosis of osteoid osteoma: from simple to challenging findings. Radiographics. 2010;30:737–49.CrossRefPubMed
7.
go back to reference Loizaga JM, Calvo M, Lopez Barea F, Martinez Tello FJ, Villanueva JP. Osteoblastoma and osteoid osteoma Clinical and morphological features of 162 cases. Pathol Res Pract. 1993;189:33–41.CrossRefPubMed Loizaga JM, Calvo M, Lopez Barea F, Martinez Tello FJ, Villanueva JP. Osteoblastoma and osteoid osteoma Clinical and morphological features of 162 cases. Pathol Res Pract. 1993;189:33–41.CrossRefPubMed
8.
go back to reference Amary F, Markert E, Berisha F, Ye H, Gerrand C, Cool P, et al. FOS expression in osteoid osteoma and osteoblastoma: a valuable ancillary diagnostic tool. Am J Surg Pathol. 2019;43:1661–7.CrossRefPubMed Amary F, Markert E, Berisha F, Ye H, Gerrand C, Cool P, et al. FOS expression in osteoid osteoma and osteoblastoma: a valuable ancillary diagnostic tool. Am J Surg Pathol. 2019;43:1661–7.CrossRefPubMed
9.
go back to reference Iyer RS, Chapman T, Chew FS. Pediatric bone imaging: diagnostic imaging of osteoid osteoma. AJR Am J Roentgenol. 2012;198:1039–52.CrossRefPubMed Iyer RS, Chapman T, Chew FS. Pediatric bone imaging: diagnostic imaging of osteoid osteoma. AJR Am J Roentgenol. 2012;198:1039–52.CrossRefPubMed
10.
go back to reference Franceschini N, Lam SW, Cleton-Jansen A-M, Bovée JVMG. What’s new in bone forming tumours of the skeleton? Virchows Arch. 2020;476:147–57.CrossRefPubMed Franceschini N, Lam SW, Cleton-Jansen A-M, Bovée JVMG. What’s new in bone forming tumours of the skeleton? Virchows Arch. 2020;476:147–57.CrossRefPubMed
11.
12.
go back to reference Trotta B, Fox MG. Benign osteoid-producing bone lesions: update on imaging and treatment. Semin Musculoskelet Radiol. 2013;17:116–22.CrossRefPubMed Trotta B, Fox MG. Benign osteoid-producing bone lesions: update on imaging and treatment. Semin Musculoskelet Radiol. 2013;17:116–22.CrossRefPubMed
13.
go back to reference Maybody M, Soliman MM, Hwang S, Gonzalez-Aguirre A, Martin EGS, Kaye E, et al. Impact of magnetic resonance imaging (MRI) findings on management of symptomatic patients following radiofrequency ablation (RFA) of osteoid osteoma (OO). SN Compr Clin Med. 2020;2:2170–7.CrossRefPubMedPubMedCentral Maybody M, Soliman MM, Hwang S, Gonzalez-Aguirre A, Martin EGS, Kaye E, et al. Impact of magnetic resonance imaging (MRI) findings on management of symptomatic patients following radiofrequency ablation (RFA) of osteoid osteoma (OO). SN Compr Clin Med. 2020;2:2170–7.CrossRefPubMedPubMedCentral
14.
go back to reference Carra BJ, Chen DC, Bui-Mansfield LT. The half-moon sign of the femoral neck is nonspecific for the diagnosis of osteoid osteoma. AJR Am J Roentgenol. 2016;206:W54.CrossRefPubMed Carra BJ, Chen DC, Bui-Mansfield LT. The half-moon sign of the femoral neck is nonspecific for the diagnosis of osteoid osteoma. AJR Am J Roentgenol. 2016;206:W54.CrossRefPubMed
15.
go back to reference Klontzas ME, Zibis AH, Karantanas AH. Osteoid osteoma of the femoral neck: use of the half-moon sign in MRI diagnosis. AJR Am J Roentgenol. 2015;205:353–7.CrossRefPubMed Klontzas ME, Zibis AH, Karantanas AH. Osteoid osteoma of the femoral neck: use of the half-moon sign in MRI diagnosis. AJR Am J Roentgenol. 2015;205:353–7.CrossRefPubMed
16.
go back to reference Fittall MW, Mifsud W, Pillay N, Ye H, Strobl A-C, Verfaillie A, et al. Recurrent rearrangements of FOS and FOSB define osteoblastoma. Nat Commun. 2018;9:2150.CrossRefPubMedPubMedCentral Fittall MW, Mifsud W, Pillay N, Ye H, Strobl A-C, Verfaillie A, et al. Recurrent rearrangements of FOS and FOSB define osteoblastoma. Nat Commun. 2018;9:2150.CrossRefPubMedPubMedCentral
17.
go back to reference Yalcinkaya U, Doganavsargil B, Sezak M, Kececi B, Argin M, Basdemir G, et al. Clinical and morphological characteristics of osteoid osteoma and osteoblastoma: a retrospective single-center analysis of 204 patients. Ann Diagn Pathol. 2014;18:319–25.CrossRefPubMed Yalcinkaya U, Doganavsargil B, Sezak M, Kececi B, Argin M, Basdemir G, et al. Clinical and morphological characteristics of osteoid osteoma and osteoblastoma: a retrospective single-center analysis of 204 patients. Ann Diagn Pathol. 2014;18:319–25.CrossRefPubMed
18.
go back to reference Izzo A, Zugaro L, Fascetti E, Bruno F, Zoccali C, Arrigoni F. Management of osteoblastoma and giant osteoid osteoma with percutaneous thermoablation techniques. J Clin Med. 2021;10:5717.CrossRefPubMedPubMedCentral Izzo A, Zugaro L, Fascetti E, Bruno F, Zoccali C, Arrigoni F. Management of osteoblastoma and giant osteoid osteoma with percutaneous thermoablation techniques. J Clin Med. 2021;10:5717.CrossRefPubMedPubMedCentral
19.
20.
go back to reference Siegel R, Miller K, Fuchs H, Jemal A. Cancer statistics, 2021. CA. 2021;71:7–33.PubMed Siegel R, Miller K, Fuchs H, Jemal A. Cancer statistics, 2021. CA. 2021;71:7–33.PubMed
21.
go back to reference Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010;23:1279–88.CrossRefPubMed Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010;23:1279–88.CrossRefPubMed
22.
go back to reference Hayashi K, Tsuchiya H, Yamamoto N, Shirai T, Nishida H, Takeuchi A, et al. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases. Int J Clin Oncol. 2014;19:731–8.CrossRefPubMed Hayashi K, Tsuchiya H, Yamamoto N, Shirai T, Nishida H, Takeuchi A, et al. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases. Int J Clin Oncol. 2014;19:731–8.CrossRefPubMed
24.
go back to reference Kelley LM, Schlegel M, Hecker-Nolting S, Kevric M, Haller B, Rössig C, et al. Pathological fracture and prognosis of high-grade osteosarcoma of the extremities: an analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients. J Clin Oncol. 2020;38:823–33.CrossRefPubMed Kelley LM, Schlegel M, Hecker-Nolting S, Kevric M, Haller B, Rössig C, et al. Pathological fracture and prognosis of high-grade osteosarcoma of the extremities: an analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients. J Clin Oncol. 2020;38:823–33.CrossRefPubMed
27.
go back to reference Ruengwanichayakun P, Gambarotti M, Frisoni T, Gibertoni D, Guaraldi F, Sbaraglia M, et al. Parosteal osteosarcoma: a monocentric retrospective analysis of 195 patients. Hum Pathol. 2019;91:11–8.CrossRefPubMed Ruengwanichayakun P, Gambarotti M, Frisoni T, Gibertoni D, Guaraldi F, Sbaraglia M, et al. Parosteal osteosarcoma: a monocentric retrospective analysis of 195 patients. Hum Pathol. 2019;91:11–8.CrossRefPubMed
28.
go back to reference Chan CM, Lindsay AD, Spiguel ARV, Gibbs CP, Scarborough MT. Periosteal osteosarcoma: a single-institutional study of factors related to oncologic outcomes. Sarcoma. 2018;2018:8631237.CrossRefPubMedPubMedCentral Chan CM, Lindsay AD, Spiguel ARV, Gibbs CP, Scarborough MT. Periosteal osteosarcoma: a single-institutional study of factors related to oncologic outcomes. Sarcoma. 2018;2018:8631237.CrossRefPubMedPubMedCentral
29.
go back to reference Cesari M, Alberghini M, Vanel D, Palmerini E, Staals EL, Longhi A, et al. Periosteal osteosarcoma: a single-institution experience. Cancer. 2011;117:1731–5.CrossRefPubMed Cesari M, Alberghini M, Vanel D, Palmerini E, Staals EL, Longhi A, et al. Periosteal osteosarcoma: a single-institution experience. Cancer. 2011;117:1731–5.CrossRefPubMed
30.
go back to reference Harper K, Sathiadoss P, Saifuddin A, Sheikh A. A review of imaging of surface sarcomas of bone. Skeletal Radiol. 2021;50:9–28.CrossRefPubMed Harper K, Sathiadoss P, Saifuddin A, Sheikh A. A review of imaging of surface sarcomas of bone. Skeletal Radiol. 2021;50:9–28.CrossRefPubMed
31.
go back to reference Murphey MD, Jelinek JS, Temple HT, Flemming DJ, Gannon FH. Imaging of periosteal osteosarcoma: radiologic-pathologic comparison. Radiology. 2004;233:129–38.CrossRefPubMed Murphey MD, Jelinek JS, Temple HT, Flemming DJ, Gannon FH. Imaging of periosteal osteosarcoma: radiologic-pathologic comparison. Radiology. 2004;233:129–38.CrossRefPubMed
32.
go back to reference Staals EL, Bacchini P, Bertoni F. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute. Cancer. 2008;112:1592–9.CrossRefPubMed Staals EL, Bacchini P, Bertoni F. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute. Cancer. 2008;112:1592–9.CrossRefPubMed
33.
go back to reference Okada K, Unni KK, Swee RG, Sim FH. High grade surface osteosarcoma: a clinicopathologic study of 46 cases. Cancer. 1999;85:1044–54.CrossRefPubMed Okada K, Unni KK, Swee RG, Sim FH. High grade surface osteosarcoma: a clinicopathologic study of 46 cases. Cancer. 1999;85:1044–54.CrossRefPubMed
34.
35.
go back to reference Kransdorf MJ, Sweet DE. Aneurysmal bone cyst: concept, controversy, clinical presentation, and imaging. AJR Am J Roentgenol. 1995;164:573–80.CrossRefPubMed Kransdorf MJ, Sweet DE. Aneurysmal bone cyst: concept, controversy, clinical presentation, and imaging. AJR Am J Roentgenol. 1995;164:573–80.CrossRefPubMed
36.
go back to reference Dahlin DC, McLeod RA. Aneurysmal bone cyst and other nonneoplastic conditions. Skeletal Radiol. 1982;8:243–50.CrossRefPubMed Dahlin DC, McLeod RA. Aneurysmal bone cyst and other nonneoplastic conditions. Skeletal Radiol. 1982;8:243–50.CrossRefPubMed
37.
go back to reference Capanna R, Springfield DS, Biagini R, Ruggieri P, Giunti A. Juxtaepiphyseal aneurysmal bone cyst. Skeletal Radiol. 1985;13:21–5.CrossRefPubMed Capanna R, Springfield DS, Biagini R, Ruggieri P, Giunti A. Juxtaepiphyseal aneurysmal bone cyst. Skeletal Radiol. 1985;13:21–5.CrossRefPubMed
38.
go back to reference Biesecker JL, Marcove RC, Huvos AG, Miké V. Aneurysmal bone cysts. A clinicopathologic study of 66 cases. Cancer. 1970;26:615–25.CrossRefPubMed Biesecker JL, Marcove RC, Huvos AG, Miké V. Aneurysmal bone cysts. A clinicopathologic study of 66 cases. Cancer. 1970;26:615–25.CrossRefPubMed
39.
go back to reference Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen C-J, Neff JR, et al. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene. 2005;24:3419–26.CrossRefPubMed Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen C-J, Neff JR, et al. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene. 2005;24:3419–26.CrossRefPubMed
40.
go back to reference Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi B-L, et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004;165:1773–80.CrossRefPubMedPubMedCentral Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi B-L, et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004;165:1773–80.CrossRefPubMedPubMedCentral
41.
go back to reference Oliveira AM, Hsi B-L, Weremowicz S, Rosenberg AE, Dal Cin P, Joseph N, et al. USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res. 2004;64:1920–3.CrossRefPubMed Oliveira AM, Hsi B-L, Weremowicz S, Rosenberg AE, Dal Cin P, Joseph N, et al. USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res. 2004;64:1920–3.CrossRefPubMed
42.
go back to reference Mendenhall WM, Zlotecki RA, Gibbs CP, Reith JD, Scarborough MT, Mendenhall NP. Aneurysmal bone cyst. Am J Clin Oncol. 2006;29:311–5.CrossRefPubMed Mendenhall WM, Zlotecki RA, Gibbs CP, Reith JD, Scarborough MT, Mendenhall NP. Aneurysmal bone cyst. Am J Clin Oncol. 2006;29:311–5.CrossRefPubMed
43.
go back to reference Martinez V, Sissons HA. Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology. Cancer. 1988;61:2291–304.CrossRefPubMed Martinez V, Sissons HA. Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology. Cancer. 1988;61:2291–304.CrossRefPubMed
45.
go back to reference Bowers LM, Cohen DM, Bhattacharyya I, Pettigrew JC, Stavropoulos MF. The non-ossifying fibroma: a case report and review of the literature. Head Neck Pathol. 2013;7:203–10.CrossRefPubMed Bowers LM, Cohen DM, Bhattacharyya I, Pettigrew JC, Stavropoulos MF. The non-ossifying fibroma: a case report and review of the literature. Head Neck Pathol. 2013;7:203–10.CrossRefPubMed
46.
go back to reference Betsy M, Kupersmith LM, Springfield DS. Metaphyseal fibrous defects. J Am Acad Orthop Surg. 2004;12:89–95.CrossRefPubMed Betsy M, Kupersmith LM, Springfield DS. Metaphyseal fibrous defects. J Am Acad Orthop Surg. 2004;12:89–95.CrossRefPubMed
47.
go back to reference Baumhoer D, Kovac M, Sperveslage J, Ameline B, Strobl A-C, Krause A, et al. Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone. J Pathol. 2019;248:116–22.CrossRefPubMed Baumhoer D, Kovac M, Sperveslage J, Ameline B, Strobl A-C, Krause A, et al. Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone. J Pathol. 2019;248:116–22.CrossRefPubMed
48.
go back to reference Brassesco MS, Valera ET, Engel EE, Nogueira-Barbosa MH, Becker AP, Scrideli CA, et al. Clonal complex chromosome aberration in non-ossifying fibroma. Pediatr Blood Cancer. 2010;54:764–7.CrossRefPubMed Brassesco MS, Valera ET, Engel EE, Nogueira-Barbosa MH, Becker AP, Scrideli CA, et al. Clonal complex chromosome aberration in non-ossifying fibroma. Pediatr Blood Cancer. 2010;54:764–7.CrossRefPubMed
49.
go back to reference Stewart DR, Brems H, Gomes AG, Ruppert SL, Callens T, Williams J, et al. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder. Genet Med. 2014;16:448–59.CrossRefPubMed Stewart DR, Brems H, Gomes AG, Ruppert SL, Callens T, Williams J, et al. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder. Genet Med. 2014;16:448–59.CrossRefPubMed
50.
go back to reference Moser RP, Sweet DE, Haseman DB, Madewell JE. Multiple skeletal fibroxanthomas: radiologic-pathologic correlation of 72 cases. Skeletal Radiol. 1987;16:353–9.CrossRefPubMed Moser RP, Sweet DE, Haseman DB, Madewell JE. Multiple skeletal fibroxanthomas: radiologic-pathologic correlation of 72 cases. Skeletal Radiol. 1987;16:353–9.CrossRefPubMed
51.
go back to reference Brothman AR, Persons DL, Shaffer LG. Nomenclature evolution: changes in the ISCN from the 2005 to the 2009 edition. Cytogenet Genome Res. 2009;127:1–4.CrossRefPubMed Brothman AR, Persons DL, Shaffer LG. Nomenclature evolution: changes in the ISCN from the 2005 to the 2009 edition. Cytogenet Genome Res. 2009;127:1–4.CrossRefPubMed
52.
go back to reference Blau RA, Zwick DL, Westphal RA. Multiple non-ossifying fibromas. A case report. J Bone Joint Surg Am. 1988;70:299–304.CrossRefPubMed Blau RA, Zwick DL, Westphal RA. Multiple non-ossifying fibromas. A case report. J Bone Joint Surg Am. 1988;70:299–304.CrossRefPubMed
53.
go back to reference Aldred MJ, Breckon JJ, Holland CS. Non-osteogenic fibroma of the mandibular condyle. Br J Oral Maxillofac Surg. 1989;27:412–6.CrossRefPubMed Aldred MJ, Breckon JJ, Holland CS. Non-osteogenic fibroma of the mandibular condyle. Br J Oral Maxillofac Surg. 1989;27:412–6.CrossRefPubMed
54.
go back to reference Goldin AN, Muzykewicz DA, Mubarak SJ. Nonossifying fibromas: a computed tomography-based criteria to predict fracture risk. J Pediatr Orthop. 2020;40:e149–54.CrossRefPubMed Goldin AN, Muzykewicz DA, Mubarak SJ. Nonossifying fibromas: a computed tomography-based criteria to predict fracture risk. J Pediatr Orthop. 2020;40:e149–54.CrossRefPubMed
55.
go back to reference Mankin HJ, Trahan CA, Fondren G, Mankin CJ. Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: a biologic and clinical review. Chir Organi Mov. 2009;93:1–7.PubMed Mankin HJ, Trahan CA, Fondren G, Mankin CJ. Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: a biologic and clinical review. Chir Organi Mov. 2009;93:1–7.PubMed
56.
go back to reference Hoeffel JC, Metaizeau JP, Lascombes P, Aymard B, Galloy MA. Cystic degeneration in non-ossifying fibroma. Eur J Pediatr Surg. 1992;2:374–7.CrossRefPubMed Hoeffel JC, Metaizeau JP, Lascombes P, Aymard B, Galloy MA. Cystic degeneration in non-ossifying fibroma. Eur J Pediatr Surg. 1992;2:374–7.CrossRefPubMed
57.
go back to reference Jee WH, Choe BY, Kang HS, Suh KJ, Suh JS, Ryu KN, et al. Nonossifying fibroma: characteristics at MR imaging with pathologic correlation. Radiology. 1998;209:197–202.CrossRefPubMed Jee WH, Choe BY, Kang HS, Suh KJ, Suh JS, Ryu KN, et al. Nonossifying fibroma: characteristics at MR imaging with pathologic correlation. Radiology. 1998;209:197–202.CrossRefPubMed
58.
go back to reference Klein MH, Rosenberg ZS, Lehman WB. Nonossifying fibroma of bone: a case report. Bull Hosp Jt Dis Orthop Inst. 1990;50:64–9.PubMed Klein MH, Rosenberg ZS, Lehman WB. Nonossifying fibroma of bone: a case report. Bull Hosp Jt Dis Orthop Inst. 1990;50:64–9.PubMed
59.
go back to reference Salassa RM, Jowsey J, Arnaud CD. Hypophosphatemic osteomalacia associated with “nonendocrine” tumors. N Engl J Med. 1970;283:65–70.CrossRefPubMed Salassa RM, Jowsey J, Arnaud CD. Hypophosphatemic osteomalacia associated with “nonendocrine” tumors. N Engl J Med. 1970;283:65–70.CrossRefPubMed
60.
go back to reference Asnes RS, Berdon WE, Bassett CA. Hypophosphatemic rickets in an adolescent cured by excision of a nonossifying fibroma. Clin Pediatr (Phila). 1981;20:646–8.CrossRefPubMed Asnes RS, Berdon WE, Bassett CA. Hypophosphatemic rickets in an adolescent cured by excision of a nonossifying fibroma. Clin Pediatr (Phila). 1981;20:646–8.CrossRefPubMed
61.
go back to reference Pollack JA, Schiller AL, Crawford JD. Rickets and myopathy cured by removal of a nonossifying fibroma of bone. Pediatrics. 1973;52:364–71.CrossRefPubMed Pollack JA, Schiller AL, Crawford JD. Rickets and myopathy cured by removal of a nonossifying fibroma of bone. Pediatrics. 1973;52:364–71.CrossRefPubMed
Metadata
Title
Update of pediatric bone tumors: osteogenic tumors and osteoclastic giant cell-rich tumors
Authors
Khalid Al-Dasuqi
Ryan Cheng
Jay Moran
Lina Irshaid
Ezekiel Maloney
Jack Porrino
Publication date
03-11-2022
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 4/2023
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-022-04221-3

Other articles of this Issue 4/2023

Skeletal Radiology 4/2023 Go to the issue